Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
      Biotech

      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

      November 2, 2026
      Mesoblast Board Changes
      Biotech

      Mesoblast Board Changes

      November 1, 2026
      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
      Biotech

      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

      November 1, 2026
      Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026
      Biotech

      Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

      October 31, 2026
      Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
      Biotech

      Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities

      October 31, 2026
      Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia
      Biotech

      Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia

      October 31, 2026
      Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.
      Biotech

      Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.

      October 30, 2026
      BioArctic’s Nomination Committee appointed
      Biotech

      BioArctic’s Nomination Committee appointed

      October 30, 2026
      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
      Biotech

      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE

      October 30, 2026
      Actinium Pharmaceuticals Announces Inducement Grant to New Employee
      Biotech

      Actinium Pharmaceuticals Announces Inducement Grant to New Employee

      October 30, 2026
      1 2 3 … 162 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026